Does Dr. CYNTHIA FIELD have financial conflicts of interest?

Dr. CYNTHIA FIELD (M.D.) has received a total of $556 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $556 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. CYNTHIA FIELD?

According to CMS Open Payments data, Dr. CYNTHIA FIELD received funding from SUPERNUS PHARMACEUTICALS ($433), CORIUM ($55), and TAKEDA PHARMACEUTICALS U.S.A ($50).

Does Dr. CYNTHIA FIELD receive research grants or speaking fees?

Dr. CYNTHIA FIELD has received $556 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. CYNTHIA FIELD

M.D.Real-Time Hydrated

Specialty: Pediatrics, Developmental - Behavioral Pediatrics

Practice Location: JACKSON, MS 39216

NPI Number: 1982634937

LIFETIME INDUSTRY VALUE

$556

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. FIELD is a verified Pediatrics, Developmental - Behavioral Pediatrics practitioner based in JACKSON, MS.

Between 2021 and 2024, Dr. FIELD had an overall industry promotional and research financial footprint of $556 as recorded in the federal CMS Open Payments database.

$556 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. FIELD's primary funding source is SUPERNUS PHARMACEUTICALS, which accounts for $433 (representing 78% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

SUPERNUS PHARMACEUTICALS

Rank 1

$433

78%

CORIUM

Rank 2

$55

9.9%

TAKEDA PHARMACEUTICALS U.S.A

Rank 3

$50

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.